Literature DB >> 7541047

Electroporation of pp60c-src antibodies inhibits the angiotensin II activation of phospholipase C-gamma 1 in rat aortic smooth muscle cells.

M B Marrero1, B Schieffer, W G Paxton, E Schieffer, K E Bernstein.   

Abstract

Our previous study has shown that angiotensin II induces the rapid tyrosine phosphorylation and activation of phospholipase C-gamma 1 in cultured rat aortic smooth muscle (RASM) cells (Marrero, M.B., Paxton, W.G., Duff, J. L., Berk, B. C., and Bernstein, K. E. (1994) J. Biol. Chem, 269, 10935-10939). This signaling pathway is initiated by ligand binding to the AT1 receptor, a cell surface G protein-coupled receptor. Antibodies to pp60c-src were introduced into RASM cells by electroporation. Angiotensin II-stimulated tyrosine phosphorylation of phospholipase C-gamma 1 was eliminated by the anti-pp60c-src antibodies but not by anti-mouse IgG or bovine serum albumin. Angiotensin II also induced the rapid tyrosine phosphorylation of pp120, a known pp60c-src kinase substrate, and this phosphorylation was also specifically inhibited by anti-pp60c-src antibodies. Electroporation of RASM cells with anti-pp60c-src antibodies had no effect on platelet-derived growth factor-stimulated tyrosine phosphorylation of PLC-gamma 1. Anti-pp60c-src also reduced the angiotensin II-stimulated inositol 1,4,5-trisphosphate production by 78%, while it had no effect on the platelet-derived growth factor-stimulated inositol 1,4,5-trisphosphate production. These data provide the first evidence for a direct involvement of pp60c-src kinase in angiotensin II-mediated PLC-gamma 1 phosphorylation and activation. Furthermore, it also describes a pathway in which a seven-transmembrane receptor can stimulate an intracellular tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541047     DOI: 10.1074/jbc.270.26.15734

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 2.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

3.  Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion.

Authors:  Hiroshi Nozawa; Gina Howell; Shinsuke Suzuki; Qing Zhang; Yanjun Qi; Judith Klein-Seetharaman; Alan Wells; Jennifer R Grandis; Sufi M Thomas
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

Review 4.  The role of tyrosine phosphorylation in angiotensin II mediated intracellular signaling and cell growth.

Authors:  B Schieffer; K E Bernstein; M B Marrero
Journal:  J Mol Med (Berl)       Date:  1996-02       Impact factor: 4.599

5.  Purinergic stimulation of rat cardiomyocytes induces tyrosine phosphorylation and membrane association of phospholipase C gamma: a major mechanism for InsP3 generation.

Authors:  M Puceat; G Vassort
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

6.  A vector-free microfluidic platform for intracellular delivery.

Authors:  Armon Sharei; Janet Zoldan; Andrea Adamo; Woo Young Sim; Nahyun Cho; Emily Jackson; Shirley Mao; Sabine Schneider; Min-Joon Han; Abigail Lytton-Jean; Pamela A Basto; Siddharth Jhunjhunwala; Jungmin Lee; Daniel A Heller; Jeon Woong Kang; George C Hartoularos; Kwang-Soo Kim; Daniel G Anderson; Robert Langer; Klavs F Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

7.  Tyrosine kinase involvement in renal arteriolar constrictor responses to angiotensin II.

Authors:  P K Carmines; R W Fallet; Q Che; K Fujiwara
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

8.  1,25 dihydroxyvitamin D3 stimulates phospholipase C-gamma in rat colonocytes: role of c-Src in PLC-gamma activation.

Authors:  S Khare; M J Bolt; R K Wali; S F Skarosi; H K Roy; S Niedziela; B Scaglione-Sewell; B Aquino; C Abraham; M D Sitrin; T A Brasitus; M Bissonnette
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

Review 9.  Arsenic carcinogenicity: relevance of c-Src activation.

Authors:  Petia P Simeonova; Michael I Luster
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

10.  Role of p22phox in angiotensin II and platelet-derived growth factor AA induced activator protein 1 activation in vascular smooth muscle cells.

Authors:  Christiane Viedt; Jianwei Fei; Heidemarie I Krieger-Brauer; Ralf P Brandes; Daniel Teupser; Motohiro Kamimura; Hugo A Katus; Jörg Kreuzer
Journal:  J Mol Med (Berl)       Date:  2003-12-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.